Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox A for Refractory Urge Incontinence
NCT00373789Phase 3Terminated
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 2006
- Primary completion
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in urge urinary incontinence (UUI), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jun 2006; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT00373789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373789.